The Near-Term Future of Exosome Science with Capricor Therapeutics' Dr. Linda Marbán

<p>Dr. Linda Marbán, Ph.D., CEO of Capricor Therapeutics, a clinical-stage biotech focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases, joins Cell &amp; Gene: The Podcast&apos;s Erin Harris to discuss the current state and the near-term future of exosomes. Marbán discusses Capricor’s exosome program and the company’s proprietary allogeneic cardiosphere-derived cells (CDCs) and engineered exosomes. She also covers the company&apos;s HOPE clinical trial series&apos; progress to treat Duchenne muscular dystrophy (DMD).</p>